Founded in 2009, DoePharma Science specializes in the development of advanced intermediaries and fine chemicals. We have undertaken and successfully completed an extensive portfolio of projects, ranging from the development of new products to the outsourcing of established processes. Our expertise ranges from processing single step reactions to managing complex multi-stage synthesis of advanced intermediates.

DoePharma is a high-tech enterprise concentrated on project development, SGLT2&Xa Inhibitor APIs & intermediates manufacturing, and pharmaceutical product CDMO&CMO service.

DOE believe in the management philosophy “achieve and maximize mutual benefit, backed with integrity.”

Looking forward to be your partner!